Ila Sri Bharati

822 total citations
12 papers, 665 citations indexed

About

Ila Sri Bharati is a scholar working on Molecular Biology, Genetics and Social Psychology. According to data from OpenAlex, Ila Sri Bharati has authored 12 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Social Psychology. Recurrent topics in Ila Sri Bharati's work include Chronic Lymphocytic Leukemia Research (3 papers), Phosphodiesterase function and regulation (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Ila Sri Bharati is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Phosphodiesterase function and regulation (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Ila Sri Bharati collaborates with scholars based in United States, Sweden and France. Ila Sri Bharati's co-authors include James L. Goodson, Davorka Messmer, Natsuko Nomura, Sandra Pastorino, Thomas J. Kipps, Ying S. Chao, Sandeep C. Pingle, Pengfei Jiang, Santosh Kesari and Valentina Fogal and has published in prestigious journals such as Blood, Neuroscience and British Journal of Cancer.

In The Last Decade

Ila Sri Bharati

12 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ila Sri Bharati United States 11 310 156 133 118 71 12 665
Patrice Roll France 19 615 2.0× 129 0.8× 43 0.3× 86 0.7× 53 0.7× 54 1.0k
Barbara Incerti Italy 16 830 2.7× 32 0.2× 48 0.4× 32 0.3× 58 0.8× 18 1.6k
T. Mohandas United States 18 627 2.0× 64 0.4× 45 0.3× 36 0.3× 26 0.4× 39 1.1k
Michal Caspi Israel 18 854 2.8× 123 0.8× 35 0.3× 134 1.1× 61 0.9× 31 1.3k
Eric van den Akker Netherlands 14 729 2.4× 68 0.4× 21 0.2× 102 0.9× 46 0.6× 18 937
Daniel Nedelcu United States 7 659 2.1× 60 0.4× 34 0.3× 74 0.6× 22 0.3× 7 782
Margit Schraders Netherlands 20 717 2.3× 386 2.5× 127 1.0× 150 1.3× 57 0.8× 32 1.5k
Toshiyuki Kobayashi Japan 18 720 2.3× 90 0.6× 27 0.2× 106 0.9× 66 0.9× 48 1.2k
Marion Butler Ireland 10 254 0.8× 103 0.7× 109 0.8× 166 1.4× 259 3.6× 14 725
Sylvie Ozon France 14 606 2.0× 41 0.3× 31 0.2× 124 1.1× 40 0.6× 15 1.1k

Countries citing papers authored by Ila Sri Bharati

Since Specialization
Citations

This map shows the geographic impact of Ila Sri Bharati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ila Sri Bharati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ila Sri Bharati more than expected).

Fields of papers citing papers by Ila Sri Bharati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ila Sri Bharati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ila Sri Bharati. The network helps show where Ila Sri Bharati may publish in the future.

Co-authorship network of co-authors of Ila Sri Bharati

This figure shows the co-authorship network connecting the top 25 collaborators of Ila Sri Bharati. A scholar is included among the top collaborators of Ila Sri Bharati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ila Sri Bharati. Ila Sri Bharati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Jiang, Pengfei, Ying S. Chao, Ila Sri Bharati, et al.. (2014). Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs. Journal of Translational Medicine. 12(1). 13–13. 92 indexed citations
3.
Pingle, Sandeep C., Sandra Pastorino, Pengfei Jiang, et al.. (2014). In silico modeling predicts drug sensitivity of patient-derived cancer cells. Journal of Translational Medicine. 12(1). 128–128. 25 indexed citations
4.
Jiang, Pengfei, Rajesh Mukthavaram, Ying S. Chao, et al.. (2014). In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells. British Journal of Cancer. 111(8). 1562–1571. 157 indexed citations
5.
Fecteau, Jessie-F., Laura G. Corral, Emanuela M. Ghia, et al.. (2014). Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21WAF1/Cip1-dependent mechanism independent of functional p53. Blood. 124(10). 1637–1644. 64 indexed citations
6.
Makale, Milan, Rajesh Mukthavaram, Pengfei Jiang, et al.. (2013). High-efficiency liposomal encapsulation of a tyrosine kinase inhibitor leads to improved in vivo toxicity and tumor response profile. International Journal of Nanomedicine. 8. 3991–3991. 27 indexed citations
7.
Fecteau, Jessie-F., Ila Sri Bharati, Morgan O’Hayre, et al.. (2011). Sorafenib-Induced Apoptosis of Chronic Lymphocytic Leukemia Cells Is Associated with Downregulation of RAF and Myeloid Cell Leukemia Sequence 1 (Mcl-1). Molecular Medicine. 18(1). 19–28. 33 indexed citations
8.
9.
Devan, Bryan D., Paul J. Pistell, Kara B. Duffy, et al.. (2007). Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor Nω-nitro-L-arginine methyl ester. European Journal of Pharmacology. 563(1-3). 134–140. 33 indexed citations
10.
Bharati, Ila Sri & James L. Goodson. (2006). Fos responses of dopamine neurons to sociosexual stimuli in male zebra finches. Neuroscience. 143(3). 661–670. 90 indexed citations
11.
Devan, Bryan D., Jonna L. Bowker, Kara B. Duffy, et al.. (2005). Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition. Psychopharmacology. 183(4). 439–445. 70 indexed citations
12.
Devan, Bryan D., Kara B. Duffy, Jonna L. Bowker, et al.. (2005). Phosphodiesterase type 5 (PDE5) inhibition and cognitive enhancement. Drugs of the Future. 30(7). 725–725. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrice Roll Breakdown of academic impact, for papers by Barbara Incerti Breakdown of academic impact, for papers by T. Mohandas Breakdown of academic impact, for papers by Michal Caspi Breakdown of academic impact, for papers by Eric van den Akker Breakdown of academic impact, for papers by Daniel Nedelcu Breakdown of academic impact, for papers by Margit Schraders Breakdown of academic impact, for papers by Toshiyuki Kobayashi Breakdown of academic impact, for papers by Marion Butler Breakdown of academic impact, for papers by Sylvie Ozon
Rankless by CCL
2026